Skip to content

LENSAR, Inc. LNSR Free cash flow yield

Free cash flow yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
Staar Surgical logo
Staar SurgicalSTAA
-4.3%+1.3pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.9%+1.7pp
RxSight, Inc. logo
RxSight, Inc.RXST
-8.5%-12.3pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-9.9%-22.8pp
IAR
Integra LifeSciencesIART
2.6%-2.1pp

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-47.4%
Enterprise value$65.21M-49.0%
P/E2.4×
P/S1.2×-1.1×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on trailing twelve months.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s free cash flow yield?
LENSAR, Inc. (LNSR) reported free cash flow yield of -11.2% in Q4 2025.
What is the long-term trend for LENSAR, Inc.'s free cash flow yield?
Over 4 years (2020 to 2025), LENSAR, Inc.'s free cash flow yield has grown at a -14.8% compound annual growth rate (CAGR), from -21.3% to -11.2%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.